Tilray Shares Propel on Trump Endorsement of CBD Benefits
27 days ago
Tom Keen/Paul Sweeney
"President Donald Trump posted a video on social media over the weekend praising the medical benefits of hemp-derived CBD for seniors, suggesting it could save $64 billion annually if fully integrated into healthcare."
Tilray Brands (TLRY) saw a 16% surge in its share price following President Trump endorsement of hemp-derived CBD for seniors. The comment emphasizes the potential for cannabis to yield economic benefits and positive cost savings when integrated into healthcare, providing a bullish catalyst for the stock in the short term.
Scores
Alpha Potential
7.0/10
Novelty
7.0/10
Credibility
7.0/10
Timeliness
9.0/10
Overall
7.6/10
Sentiment
Bullish
Conviction
Medium
Tier
Company Commentary
Related Stocks
Episode Information
Episode:
EA Soars on LBO Report; Weed Stocks Rise on Trump Comments; Genmab-Merus Acquistion
Source:Stock Movers
Published:
September 29, 2025
Idea Type:
Sentiment Shift